Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers have made a breakthrough in more precisely targeting drugs to cancers. Using ultrasound and lipid drug carriers (liposomes), a multi-disciplinary team of biomedical engineers, oncologists, radiologists and anaesthetists at the University of Oxford have developed a new way to improve the targeting of cancer drugs to tumours.

None © Celsion

Meet the lead author of the study

  • Paul Lyon
    Paul Lyon

    Senior Research Fellow in Interventional Oncology

Similar stories

Pump-priming grants available as 2026 Innovation Competition open for entries

The Quality in Organ Donation (QUOD) programme at the Nuffield Department of Surgical Sciences is excited to announce that applications are open for the 2026 Innovation Competition, a partnership between the charity Live Life Give Life, QUOD and the British Transplantation Society (BTS).